Riskpilot← Back to searchSign inGet full accessMedilex AB
ABIn liquidationOrg 5569514788 · NACE Est. 20130 employees
Revenue 2019
SEK 0
EBITDA margin
—
-6% vs 2018
Equity ratio
98.3%
Financial strength
Net profit 2019
SEK 74K
+72% vs 2018
| Revenue | SEK 0 | — |
| EBITDA | SEK -17K | -6% |
| Net profit | SEK 74K | +72% |
| Total assets | SEK 4,6M | -1% |
| Equity | SEK 4,5M | -2% |
| Employees | 0 | — |
Legal name
Medilex AB
Org number
5569514788
Legal form
Aktiebolag
NACE code
·
Founded
2 december 2013
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-08-31
Financial year
January – December
Company purpose
Aktiebolaget ska bedriva verksamhet med sjukvård, främst inom urologi, gynekologi och uroterapi, och försäljning av sjukvårds- artiklar jämte därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | −17 | −18 | −16 | −17 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −17 | −18 | −16 | −17 |
| Net financials | 57 | 14 | 70 | 112 |
| Profit before tax | 40 | −4 | 54 | 95 |
| Tax | −9 | −0 | −11 | −21 |
| Net profit | 31 | −4 | 43 | 74 |
| Item | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Total assets | 5 057 | 4 744 | 4 620 | 4 554 |
| Equity | 5 031 | 4 702 | 4 574 | 4 478 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 26 | 42 | 45 | 76 |
| Total debt | 26 | 42 | 45 | 76 |
EBITDA margin
-1700000.0%
This company
15.8%
Market median
-10759594% vs market
20162019
Equity ratio
98.3%
This company
38.2%
Market median
+157% vs market
20162019
Return on equity
1.7%
This company
18.4%
Market median
-91% vs market
20162019
Net profit margin
7400000.0%
This company
8.1%
Market median
+91357925% vs market
20162019
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162019
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20162019
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
IM Liquidator | Liquidator | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2020 – 2020 | |
| Deputy Board Member | 2020 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medilex AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Izabela Maria Tuszynska | Liquidator | 0 companies |
| Margareta Lexmark | Board of Directors | 0 companies |
| Jenny Maria Lexmark Lindberg | Deputy Board Member | 0 companies |